TMPRSS2-ERG confers resistance of prostate cancer to antiandrogensArunachalam Sekar(Weizmann Institute of Science), Yosef Yarden(Weizmann Institute of Science)EMBO Molecular MedicineMay 12, 202610.1038/s44321-026-00423-7Cited by 0SaveCiteExport RISWatch citationsRelated PapersPD-L1 recruits phospholipase C and enhances tumorigenicity of lung tumors harboring mutant forms of EGFR|Cell Reports|2021|44